Stavros G. Vizirgianakis, Director at Xtant Medical Holdings, Inc. (XTNT), bought 4,529,722 shares at $0.48 ($2.2M) on 2022-10-07, disclosed to the SEC on 2022-10-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.48 | 2,264,861 | $1.1M | 50.0% |
| 2 | $0.48 | 2,264,861 | $1.1M | 50.0% |
| Total | $0.48 avg | 4,529,722 | $2.2M | 100% |
| Filing → |
| MSON | BUY | 2014-06-18 | $396K | — | Filing → |